ArticleCells2023

Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3.

Antonio Arulanandam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.